Annual report pursuant to Section 13 and 15(d)

Other liabilities

v3.5.0.2
Other liabilities
 12 Months Ended
Jul. 31, 2016
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]  
Other Liabilities Disclosure [Text Block]

Note 9 - Other liabilities


At July 31 Other liabilities consist of:


    2016     2015  
Accrued legal settlement – see Note 14   $ 800     $ 1,220  
Capital lease obligation     794       210  
Installment loans     105       363  
    $ 1,699     $ 1,793  

The capital lease obligation and Installment loans are for machinery and equipment used in the Clinical Labs segment. Amortization of the assets recorded under the capital lease is included in depreciation expense. At July 31, 2016, the accumulated amortization on the capital lease was $271 and the imputed interest rate ranges from 4.3% to 9.5%.


Future minimum lease and loan payments are as follows:


    Capital lease     Installment
loans		  
2017   $ 307     $ 236  
2018     299       97  
2019     258       9  
2020     250       —  
2021     198       —  
Total payments     1,312       342  
Less: interest     (211 )     (1 )
Total net of interest     1,101       341  
Less: current portion     (307 )     (236 )
Other liabilities - net   $ 794     $ 105  

The weighted average interest rate on our short term borrowings during fiscal 2016 and 2015 was 8.0% and 2.7%, respectively.